Nour Ali Obeidat

Dr. Nour Ali Obeidat

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Schizophrenia Research
Verified
Journal Article
Closed access
CMC. Daniel Mullins
C. Daniel Mullins
NONour Ali Obeidat
Nour Ali Obeidat
BCBrian J. Cuffel
Brian J. Cuffel
JNJohn Naradzay
John Naradzay
ALAntony D. Loebel
Antony D. Loebel

1 February 2023 in Journal of Physical Activity and Health
Verified
Journal Article
Open access
PDF file
ARAndrea Ramirez
Andrea Ramirez
PHPedro C. Hallal
Pedro C. Hallal
JGJuliana Mejía Grueso
Juliana Mejía Grueso
ZPZeljko Pedisic
Zeljko Pedisic
DSDeborah Salvo
Deborah Salvo
MPMichael Pratt
Michael Pratt
Background: Physical activity (PA) surveillance, policy, and research efforts need to be periodically appraised to gain insight into national and global capacities for PA promotion. The aim of this paper was to assess the status and trends in PA surveillance, policy, and research in 164 countries. Methods: We used data from the Global Observatory for Physical Activity (GoPA!) 2015 and 2020 surveys. Comprehensive searches were performed for each country to determine the level of development of their PA surveillance, policy, and research, and the findings were verified by the GoPA! Country Contacts. Trends were analyzed based on the data available for both survey years. Results: The global 5-year progress in all 3 indicators was modest, with most countries either improving or staying at the same level. PA surveillance, policy, and research improved or remained at a high level in 48.1%, 40.6%, and 42.1% of the countries, respectively. PA surveillance, policy, and research scores decreased or remained at a low level in 8.3%, 15.8%, and 28.6% of the countries, respectively. The highest capacity for PA promotion was found in Europe, the lowest in Africa and low- and lower-middle-income countries. Although a large percentage of the world’s population benefit from at least some PA policy, surveillance, and research efforts in their countries, 49.6 million people are without PA surveillance, 629.4 million people are without PA policy, and 108.7 million live in countries without any PA research output. A total of 6.3 billion people or 88.2% of the world’s population live in countries where PA promotion capacity should be significantly improved. Conclusion: Despite PA is essential for health, there are large inequalities between countries and world regions in their capacity to promote PA. Coordinated efforts are needed to reduce the inequalities and improve the global capacity for PA promotion.
1

2 August 2013 in Inhalation Toxicology
Verified
Journal Article
Closed access
FHFeras I. Hawari
Feras I. Hawari
NONour Ali Obeidat
Nour Ali Obeidat
HAHiba Ayub
Hiba Ayub
IGIyad Ghonimat
Iyad Ghonimat
TEThomas Eissenberg
Thomas Eissenberg
HBHamza Beano
Hamza Beano
Context: Waterpipe tobacco smoking (WTS) has gained popularity, but its physiologic effects have not been extensively studied: rather, studies have focused on WTS’s chronic effects or have evaluated limited respiratory/cardiac parameters. Objective: We sought to characterize in a more detailed manner the acute effects of WTS on lung function and exercise capacity. Method: We recruited 24 healthy WTS males. We used a pilot single-group pre-test (abstained from WTS for ≥48 h) post-test (within 0.5 h of a 45-min WTS session) design. We performed spirometry, diffusing lung capacity and time-limited CPE testing (CPET; cycloergometer; 2-min 20-Watt warm-up and 25-Watt increase every 2-min for 10 min). Results: Mean age was 20.4 years; Post-WTS, the following significant changes were observed: CO level increased from 3.7 ppm to 24.4; oxygen consumption decreased (from 1.86 L/min to 1.7); baseline respiratory rate increased (from 17.7 breath/min to 19.7); forced expiratory flow over the middle half of the forced vital capacity decreased (from 5.51 L to 5.29); and perceived exertion (measured by Borg scale) at mid and peak exercise increased. Baseline resting systolic blood pressure, pulse pressure, and pulse pressure product increased post-WTS (from 118.9 mmHg to 129.2; from 45.3 mmHg to 55.6; and from 9.9 mmHg/min to 11.1 post-WTS, respectively). During exercise, a decrease in oxygen pulse was observed post-WTS (from 10.89 ml/beat to 9.97), while the heart rate-oxygen consumption relationship increased post-WTS (from 3.52 beats/ml/kg to 3.91). Conclusion: Acute WTS appears to induce impairment in lung function and exercise capacity. Larger studies are warranted to further characterize the nature and extent of such impairment.

1 August 2006 in Clinical Therapeutics
Verified
Journal Article
Closed access
CMC. Daniel Mullins
C. Daniel Mullins
AKAndreas Kuznik
Andreas Kuznik
FSFadia T. Shaya
Fadia T. Shaya
NONour Ali Obeidat
Nour Ali Obeidat
ALAndrew R. Levine
Andrew R. Levine
WWWinston Wong
Winston Wong

1 November 2007 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
PDF file
FPFrançoise G. Pradel
Françoise G. Pradel
NONour Ali Obeidat
Nour Ali Obeidat
MTMona G. Tsoukleris
Mona G. Tsoukleris

31 January 2024 in Global Heart
Verified
Journal Article
Open access
PDF file
EDE. Ulysses Dorotheo
E. Ulysses Dorotheo
MAMonika Arora
Monika Arora
ABAmitava Banerjee
Amitava Banerjee
EBEduardo Bianco
Eduardo Bianco
NCNuan Ping Cheah
Nuan Ping Cheah
YWYunshu Wang
Yunshu Wang
Nicotine is universally recognized as the primary addictive substance fuelling the continued use of tobacco products, which are responsible for over 8 million deaths annually. In recent years, the popularity of newer recreational nicotine products has surged drastically in many countries, raising health and safety concerns. For decades, the tobacco industry has promoted the myth that nicotine is as harmless as caffeine. Nonetheless, evidence shows that nicotine is far from innocuous, even on its own. In fact, numerous studies have demonstrated that nicotine can harm multiple organs, including the respiratory and cardiovascular systems. Tobacco and recreational nicotine products are commercialized in various types and forms, delivering varying levels of nicotine along with other toxic compounds. These products deliver nicotine in profiles that can initiate and perpetuate addiction, especially in young populations. Notably, some electronic nicotine delivery systems (ENDS) and heated tobacco products (HTP) can deliver concentrations of nicotine that are comparable to those of traditional cigarettes. Despite being regularly advertised as such, ENDS and HTP have demonstrated limited effectiveness as tobacco cessation aids in real-world settings. Furthermore, ENDS have also been associated with an increased risk of cardiovascular disease. In contrast, nicotine replacement therapies (NRT) are proven to be safe and effective medications for tobacco cessation. NRTs are designed to release nicotine in a slow and controlled manner, thereby minimizing the potential for abuse. Moreover, the long-term safety of NRTs has been extensively studied and documented. The vast majority of tobacco and nicotine products available in the market currently contain nicotine derived from tobacco leaves. However, advancements in the chemical synthesis of nicotine have introduced an economically viable alternative source. The tobacco industry has been exploiting synthetic nicotine to circumvent existing tobacco control laws and regulations. The emergence of newer tobacco and recreational nicotine products, along with synthetic nicotine, pose a tangible threat to established tobacco control policies. Nicotine regulations need to be responsive to address these evolving challenges. As such, governments should regulate all tobacco and non-medical nicotine products through a global, comprehensive, and consistent approach in order to safeguard tobacco control progress in past decades.